Literature DB >> 34978266

Impact of seminal low-risk human papillomavirus infection on sperm parameters of adult men.

Rossella Cannarella1, Antonio Aversa2, Rosita A Condorelli1, Silvia De Cristofaro1, Emanuela Greco3, Agata Grillo4, Aldo E Calogero1, Sandro La Vignera1.   

Abstract

Aim: We aimed to evaluate the impact of seminal low-risk human Papillomavirus (LR-HPV) infection on sperm conventional parameters.Material and methods: This was a retrospective case-control study including patients attending to our center for infertility. Patients with evidence for high risk (HR)-HPV infection previously or at the time of enrollment, and/or with severe oligozoospermia (sperm concentration <5 mil/ml) were ruled out. Twenty selected patients positive for a LR-HPV and 20 control subjects with no evidence of HPV DNA and with available results of sperm analysis were consecutively enrolled.
Results: Patients positive for LR-HPV had a mean age of 31.0 + 11.0 years, while controls were 35.0 + 8.0-year-old (p > .05). Sperm concentration, total sperm count, sperm progressive motility, morphology, and leukocyte concentration did not differ between patients and controls. However, the prevalence of oligozoospermia was significantly higher in patients than controls (50% vs. 15%). No difference in the prevalence of astenozoospermia (30% vs. 40%) or teratozoospermia (15% vs. 15%) was found.
Conclusion: We found no difference in sperm conventional parameters in LR-HPV infected patients than in controls. These data might prompt to research the impact on LR-HPV genotype on male fertility. Particularly, evidence on sperm DNA fragmentation (SDF) and pregnancy outcome is needed.

Entities:  

Keywords:  Low-risk HPV

Mesh:

Year:  2022        PMID: 34978266     DOI: 10.1080/13685538.2021.2023126

Source DB:  PubMed          Journal:  Aging Male        ISSN: 1368-5538            Impact factor:   5.892


  1 in total

1.  The Use of Ellagic Acid and Annona Muricata Improves Semen Quality in Men with High-Risk Papillomavirus Infection.

Authors:  Sandro La Vignera; Livia Basile; Antonio Aversa; Aldo E Calogero; Agata Grillo; Rossella Cannarella; Laura M Mongioì; Rosita A Condorelli
Journal:  J Clin Med       Date:  2022-08-11       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.